Health Care & Life Sciences » Pharmaceuticals | Shandong Jincheng Pharmaceutical Co. Ltd.

Shandong Jincheng Pharmaceutical Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
903
1,044
1,166
1,405
2,753
2,965
Cost of Goods Sold (COGS) incl. D&A
643
698
785
1,049
1,856
1,590
Gross Income
260
346
381
356
897
1,374
SG&A Expense
150
198
194
204
545
891
EBIT
104
140
178
163
350
476
Unusual Expense
4
-
17
1
-
128
Non Operating Income/Expense
9
9
12
12
1
25
Interest Expense
19
18
16
13
12
16
Pretax Income
81
123
173
170
341
370
Income Tax
16
15
4
14
51
88
Equity in Affiliates
-
-
-
-
-
-
Consolidated Net Income
65
109
169
156
290
282
Net Income
65
109
171
159
286
264
Net Income After Extraordinaries
65
109
171
159
286
264
Net Income Available to Common
65
109
171
159
286
264
EPS (Basic)
0.27
0.44
0.68
0.63
0.77
0.67
Basic Shares Outstanding
242
247
251
253
372
393
EPS (Diluted)
0.27
0.44
0.68
0.63
0.77
0.67
Diluted Shares Outstanding
242
247
251
253
372
393
EBITDA
161
211
261
253
504
651
Other Operating Expense
6
8
10
11
3
8
Non-Operating Interest Income
8
6
5
4
5
7
Minority Interest Expense
-
-
2
3
4
18

About Shandong Jincheng Pharmaceutical Co.

View Profile
Address
Zichuan Economic Development Zone
Zibo Shandong 255100
China
Employees -
Website http://www.jinchengpharm.com
Updated 07/08/2019
Shandong Jincheng Pharmaceutical Group Co., Ltd. engages in the research and development, production and sale of III and IV cephalosporin intermediates and bio-pharmaceuticals. Its products are categorized into the following divisions: Characteristic Bulk Drugs, Pharmaceutical Intermediates, and Fine Chemicals. The company was founded by Hong Fu Zhao on January 12, 2004 and is headquartered in Zibo, China.